Skip to main content
. 2024 May 3;43:133. doi: 10.1186/s13046-024-03047-2

Table 1.

The correlation between the fcn3 and clinicopathologic parameters in HCC patients

Characteristic High Expression Low
Expression
p value s value
Group (n = 61) Group (n = 73)
Gender
 Male 52 60 0.635 0.66
 Female 9 13
Age (years)
 < 65 45 57 0.560 0.84
 ≥ 65 16 16
Liver Cirrhosis
 No 33 44 0.472 1.08
 Yes 28 29
AFP (ng/mL)
 ≤ 400 55 55 0.023* 5.44
 > 400 6 18
Tumor Size (cm)
 ≤ 5 54 42 < 0.0001*** 13.29
 > 5 7 31
Tumor Number
 Single 53 61 0.591 0.76
 Multiple 8 12
Satellite Nodules
 No 60 69 0.243 2.04
 Yes 1 4
MVI stage
 2 4 11 0.120 3.06
 0/1 57 62
TNM stage
 I/II 38 32 0.033* 4.92
 III/IV 23 41
Recurrence
 No 47 44 0.038* 4.72
 Yes 14 29
Survival status
 Survival 53 61 0.591 0.76
 Death 8 12

HCC hepatocellular carcinoma

*p < 0.05, **p < 0.01, ***p < 0.001 values are set for highly significant differences

s value s = − log2(p)